Malaysian cities are clean and modern, its public transport unrivalled, and its people the friendliest in Asia. According to International Living, the cost of living is four times cheaper than it is in the U.S., and as an added bonus, Malaysia’s street food is hands down the best in Southeast Asia. The demand for retirement homes in Malaysia can only go up in view of the increasing number of senior citizens in need of retirement homes that are affordable with good quality related support services. In fact, Malaysia ranks among the top 10 retirement destinations globally, according to the 2025 Annual Global Retirement Index . And while other Asian countries offer great budget holidays, and some offer first-class vacations, Malaysia manages to cater extraordinarily well to both. For those who wish to retire or spend extended periods here, the Malaysia My Second Home (MM2H) programme; launched in 2002 by the Malaysian government offers a renewable, ten-year, multiple entry visa for...
Looking for recommended private home nursing providers or private nurses in Malaysia? Instead of sending your parents to stay in the old folks home or private hospitals, home nursing service providers provide qualified nurses who will assist you to take care your parents in their own home. From their preferred pillows to their preferred bed, home care provides the service they need at the comfort of their home. We believe that home care is the care of the future. Home care provides care within the comfort of your own home. The advent of modern technologies such as the internet and internet of things and affordable airlines and ride-hailing firms such as Uber and Grab, have made consumer-centric care more achievable as opposed to facility-centric care such as in hospitals and nursing homes. Home care is not just about care-givers and private nurses. The care of your loved ones will need to be personalised as there are different levels of care and the medical equipment needs are...
Ivermectin is an FDA-approved anti-parasitic drug widely used for treating several neglected tropical diseases, including onchocerciasis, strongyloidiasis and helminthiases for more than four decades. The “off-label” use of Ivermectin gained global attention due to some promising results by case studies and clinical trials. The US FDA has not approved Ivermectin for use in treating or preventing Covid-19 in humans, and the WHO only recommends the use of Ivermectin in the setting of clinical trials, in which patients are monitored closely by experienced clinicians and researchers for safety and efficacy. There is an on-going need for adequately powered, well-designed, and well-conducted clinical trials for evidence-based guidance on the role of Ivermectin in the treatment of COVID-19. Under the circumstances, the Ministry of Health Malaysia and the Institute for Clinical Research (ICR) have initiated a multicentre open-label randomized controlled trial. The I vermectin...
Comments
Post a Comment